GENEVA, July 9 -- SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD. filed a patent application (CN2024/142412) for “RECOMBINANT HUMAN HYALURONIDASE PREPARATION METHOD AND USE”. With publication no. WO/2025/140337, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: C12N 9/26
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....